Study identifier:NIS-CSG-CRE-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects with Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings
hypercholesterolaemia
-
No
-
All
800
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|